Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
Itokawa, Masanari
Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia. [electronic resource] - Journal of pharmacological sciences 2010 - 1-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1347-8648
10.1254/jphs.10r07fm doi
Alleles
Animals
Cysteine--genetics
Dopamine--physiology
Drug Discovery--methods
Humans
Mental Disorders--drug therapy
Polymorphism, Genetic--genetics
Receptors, Dopamine D2--genetics
Schizophrenia--drug therapy
Serine--genetics
Signal Transduction--drug effects
Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia. [electronic resource] - Journal of pharmacological sciences 2010 - 1-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1347-8648
10.1254/jphs.10r07fm doi
Alleles
Animals
Cysteine--genetics
Dopamine--physiology
Drug Discovery--methods
Humans
Mental Disorders--drug therapy
Polymorphism, Genetic--genetics
Receptors, Dopamine D2--genetics
Schizophrenia--drug therapy
Serine--genetics
Signal Transduction--drug effects